Viraj Master, MD, PhD, FACS

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (220 ratings)

Role

Urology
Specialty

Adrenal Cancer Bladder Cancer Kidney (Renal) Cancer Penile Cancer Prostate Cancer Testicular Cancer
Research Program

Cancer Prevention and Control
Practicing Since

2003

Call 404-778-4898

Background

Dr. Master is a Professor of Urology at the Emory University School of Medicine, Associate Chair for Clinical Affairs and Quality, and Director of Clinical Research Unit.

Following his undergraduate education at Northwestern University, Dr. Master attended medical school at the University of Chicago where he received both MD and PhD degrees. He completed his urology residency and two fellowships training at the University of California in San Francisco (UCSF) before joining the Department of Urology at Emory University in 2005. Dr. Master is a diplomate of the American Board of Urology (2006) a Fellow of the American College of Surgery (FACS).

Dr. Master’s primary clinical interest is urologic oncology, in particular kidney cancer, adrenal tumors, testicular cancer, high-risk prostate cancer and penile cancers. Dr. Master is a renowned national expert in the surgical treatment of kidney cancer particularly a complex variety that extends into the main blood vessels and the heart. He also has a special interest in minimally invasive laparoscopic technique that removes of cancerous lymph nodes with minimal interference with the patients’ quality of life.

As the Director of Clinical Research, he is active in investigating the role of inflammation in cancers and in researching “host” (patient) interaction with the disease. In his role as Associate Chair for Clinical Affairs and Quality, he works closely with all faculty members towards a common goal of providing the highest quality of care to our patients. Emory University Hospital (EUH) ranks number one hospital (out of 187) in both Georgia and metro Atlanta (2013-2014 U.S. News & World Report), and the Department of Urology ranks as one of Emory’s top ten high-performing adult specialty areas.

Dr. Master serves as an expert advisor to the American Cancer Society on prostate cancer and to the International Consultation on Urologic Diseases on kidney cancer. He has lectured both nationally and internationally. He is closely involved in teaching and mentoring medical students, urology residents and post-graduate fellows. He has authored multiple book chapters and scientific journal articles.
In addition to his dedication to Emory patients, Dr. Master is also involved in humanitarianism outside Emory. On an annual basis, he volunteers his time to join a team of Emory medical students to Haiti. The team provides free urologic care including surgical treatment to indigent Haitian patients with urologic conditions.

Titles & Roles

Professor and Fray F. Marshall Chair in Clinical Urologic Research, Department of Urology

Emory University School of Medicine
Director of Integrative Oncology and Survivorship

Winship Cancer Institute of Emory University
Director of Clinical Research, Department of Urology

Emory University School of Medicine

Education & Training

Education

Fellowship, Urology, 2003
UCSF Medical Center
Residency, Urology, 2001
UCSF Medical Center
Internship, General Surgery, 1999
UCSF Medical Center
Medical Education, MD, 1997
University of Chicago

Board Certifications

Urology
American Board of Urology, 2006

Research

View Current Clinical Trials


To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring Phase II Conditions Prostate Carcinoma Location Winship Cancer Institute
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer Phase I Conditions Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm Location Winship Cancer Institute
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) Phase III Conditions Squamous Cell Carcinoma of the Penis, Usual Type Location Winship Cancer Institute, Grady Health System

Publications

Title/Journal	Authors	Publication Date
Characterizing Psychological Resources and Resilience in Patients With Bladder Cancer: Associations With Frailty and Quality of Life. The Journal of urology	E Petersen, S Holt, A Browning, D Cavanaugh, S Jannat, J Wright, J Gore, G Schade, M Reed, J Garcia, I Bentov, V Master, D Berry, FJ Fintelmann, JP Marquardt, R O'Malley, SP Psutka	01/01/2025
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clinical genitourinary cancer	C Saitta, G Garofano, JA Afari, H Tanaka, D Patil, KL Yuen, L Wang, J Cortes, MF Meagher, D Puri, C Cerrato, MV Nguyen, K Hakimi, M Kobayashi, S Fukuda, M Paciotti, M Lazzeri, G Lughezzani, NM Buffi, Y Fujii, V Master, IH Derweesh	12/01/2024
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma. Clinical genitourinary cancer	EH Nicaise, BN Schmeusser, G Palmateer, K Vashi, K Parikh, D Patil, DD Shapiro, EJ Abel, S Joshi, V Narayan, K Ogan, VA Master	12/01/2024
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study. European urology	T El Zarif, K Semaan, W Xie, M Eid, M Zarba, W Issa, T Zhang, CB Nguyen, A Alva, CC Fahey, KE Beckermann, JA Karam, MT Campbell, G Procopio, M Stellato, S Buti, A Zemankova, B Melichar, F Massari, V Mollica, B Venugopal, H Ebrahimi, G de Velasco, HP Gurney, U De Giorgi, O Parikh, E Winquist, V Master, AR Garcia, HJ Cutuli, TR Ferguson, M Gross-Goupil, SC Baca, SK Pal, DA Braun, RR McKay, DYC Heng, TK Choueiri	12/01/2024
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010. European urology oncology	JA Karam, R Uzzo, A Bex, W Leung, C Tat, A Nicholas, A Andreev-Drakhlin, M Huseni, SK Pal, VA Master	12/01/2024
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature	MA Cardenas, N Prokhnevska, E Sobierajska, P Gregorova, CB Medina, RM Valanparambil, R Greenwald, L DelBalzo, MA Bilen, SS Joshi, VM Narayan, VA Master, MG Sanda, HT Kissick	12/01/2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer	DJ Martini, KB Case, D Gratz, K Pellegrini, E Beagle, T Schneider, M Dababneh, B Nazha, JT Brown, SS Joshi, VM Narayan, K Ogan, VA Master, BC Carthon, O Kucuk, LR Harik, MA Bilen	11/01/2024
Tailoring language for genitourinary function in patients with newly diagnosed prostate cancer to facilitate discussions in diverse populations and overcome health literacy barriers. Cancer	KL Kilbridge, D Patil, CP Filson, JW Shelton, SW Thomson, CH Rosenbaum, EC Rothmann, W Martin-Doyle, QD Trinh, VM Narayan, VA Master	10/15/2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. Clinical genitourinary cancer	JA Cortes, C Saitta, KL Yuen, D Patil, H Tanaka, D Puri, JA Afari, M Mahmood, J Matian, M Mansour, A Ahdoot, L Wang, MF Meagher, M Guer, M Dabbas, MV Nguyen, C Cerrato, M Kobayashi, S Fukuda, Y Fujii, V Master, IH Derweesh	10/01/2024
[⁸⁹Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. The Lancet. Oncology	B Shuch, AJ Pantuck, JC Bernhard, MA Morris, V Master, AM Scott, C van Praet, C Bailly, B Önal, T Aksoy, R Merkx, DM Schuster, ST Lee, N Pandit-Taskar, AC Fan, P Allman, K Schmidt, L Tauchmanova, M Wheatcroft, C Behrenbruch, CRW Hayward, P Mulders	10/01/2024
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database. Urologic oncology	F Liu, L Wang, MF Meagher, J Afari, C Saitta, S Dhanji, S Ghassemzadeh, A Shah, D Puri, MV Nguyen, K Hakimi, B Schmeusser, R Greenwald, A Medline, F Kamal, A Ali, S Fukuda, M Kobayashi, W Chen, B Fan, Y Aida, Y Maezawa, S Asai, H Tanaka, D Patil, Y Fujii, V Master, IH Derweesh	10/01/2024
A Multicenter Evaluation of Treatment-associated Changes in Body Composition in Men With Germ Cell Tumors of the Testis: Implications for Adverse Events and Complications. Urology	C Buxton, BN Schmeusser, SK Holt, D Patil, A Phuong, S Chahine, JP Marquardt, R O'Malley, G Laidlaw, GR Schade, DW Lin, MT Schweizer, T Yezefski, EY Yu, B Montgomery, FJ Fintelmann, VA Master, SP Psutka	10/01/2024
Recommendations for Healthy Lifestyle for Cancer Prevention and Healthy Aging. Journal of cancer prevention	O Kucuk, VA Master	09/30/2024
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches. The oncologist	D Chukkalore, K MacDougall, V Master, MA Bilen, B Nazha	09/06/2024
Testicular Germ Cell Tumors with Venous Tumor Thrombus: Prevalence, Presentation, and Management. European urology focus	SY Chahine, KY Alkhatib, G Arakelyan, C Buxton, G Giannarini, RJ Hamilton, SK Holt, JC Bernhard, DM Jiang, D Lin, JJ Liu, B Manley, VA Master, V Matveev, A Necchi, VT Packiam, SH Patel, T Peak, CC Peyton, PM Pierorazio, G Prakash, K Salari, WJ Sexton, N Singla, PE Spiess, SP Psutka	08/14/2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial. Research square	MA Bilen, BT Vo, Y Liu, R Greenwald, AH Davarpanah, D McGuire, R Shiradkar, L Li, B Nazha, JT Brown, S Williams, W Session, G Russler, S Caulfield, SS Joshi, VM Narayan, CP Filson, K Ogan, O Kucuk, BC Carthon, L Del Balzo, A Cohen, A Boyanton, N Prokhnevska, MA Cardenas, E Sobierajska, CS Jansen, DH Patil, E Nicaise, AO Osunkoya, H Kissick, VA Master	08/08/2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. The Lancet. Oncology	ME Allaf, SE Kim, V Master, DF McDermott, LC Harshman, SM Cole, CG Drake, S Signoretti, M Akgul, N Baniak, E Li-Ning, MB Palmer, H Emamekhoo, N Adra, H Kaimakliotis, Y Ged, PM Pierorazio, EJ Abel, MA Bilen, K Ogan, HH Moon, KA Ramaswamy, EA Singer, TM Mayer, J Lohrey, V Margulis, J Gills, SE Delacroix, MJ Waples, AC James, P Wang, T Choueiri, MD Michaelson, A Kapoor, DY Heng, B Shuch, BC Leibovich, PN Lara, J Manola, D Maskens, D Battle, R Uzzo, G Bratslavsky, NB Haas, MA Carducci	08/01/2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study. Journal of the National Cancer Institute	KM Rose, R Pham, NM Zacharias, F Ionescu, M Paravathaneni, KA Marchetti, D Sanchez, A Mustasam, R Sandstrom, R Vikram, J Dhillon, P Rao, A Schneider, L Pagliaro, C Alifrangis, M Albersen, E Roussel, VA Master, B Nazha, C Hernandez, KA Moses, C Protzel, J Montgomery, M Angel, M Tobias-Machado, PE Spiess, CA Pettaway, J Chahoud	06/07/2024
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry. Clinical genitourinary cancer	C Saitta, JA Afari, D Patil, H Tanaka, KL Yuen, L Wang, J Cortes, F Liu, M Mahmood, J Matian, M Mansour, D Puri, C Cerrato, MV Nguyen, K Hakimi, M Kobayashi, S Fukuda, MF Meagher, Y Fujii, V Master, IH Derweesh	06/01/2024
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy. Clinical genitourinary cancer	EH Nicaise, BN Schmeusser, A Ali, E Midenberg, AR Palacios, B Hartsoe, E Kearns, S Ambadi, DH Patil, SS Joshi, VM Narayan, SP Psutka, B Nazha, JT Brown, K Ogan, MA Bilen, VA Master	06/01/2024
Differences in preoperative frailty assessment of surgical candidates by sex, age, and race. Surgery open science	EH Nicaise, G Palmateer, BN Schmeusser, C Futral, Y Liu, S Goyal, R Nabavizadeh, DA Kooby, SK Maithel, JF Sweeney, JM Sarmiento, K Ogan, VA Master	06/01/2024
Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial. Surgery open science	MG House, R Kim, EE Tseng, RP Kaufman, MR Moon, A Yopp, VA Master	06/01/2024
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nature genetics	MP Purdue, D Dutta, MJ Machiela, BR Gorman, T Winter, D Okuhara, S Cleland, A Ferreiro-Iglesias, P Scheet, A Liu, C Wu, SO Antwi, J Larkin, SC Zequi, M Sun, K Hikino, A Hajiran, KA Lawson, F Cárcano, O Blanchet, B Shuch, KG Nepple, G Margue, D Sundi, WR Diver, MAAK Folgueira, A van Bokhoven, F Neffa, KM Brown, JN Hofmann, J Rhee, M Yeager, NR Cole, BD Hicks, MR Manning, AA Hutchinson, N Rothman, WY Huang, WM Linehan, A Lori, M Ferragu, M Zidane-Marinnes, SV Serrano, WJ Magnabosco, A Vilas, R Decia, F Carusso, LS Graham, K Anderson, MA Bilen, C Arciero, I Pellegrin, S Ricard, G Scelo, RE Banks, NS Vasudev, N Soomro, GD Stewart, A Adeyoju, S Bromage, D Hrouda, N Gibbons, P Patel, M Sullivan, A Protheroe, FI Nugent, MJ Fournier, X Zhang, LJ Martin, M Komisarenko, T Eisen, SA Cunningham, DC Connolly, RG Uzzo, D Zaridze, A Mukeria, I Holcatova, A Hornakova, L Foretova, V Janout, D Mates, V Jinga, S Rascu, M Mijuskovic, S Savic, S Milosavljevic, V Gaborieau, B Abedi-Ardekani, J McKay, M Johansson, L Phouthavongsy, L Hayman, J Li, I Lungu, SM Bezerra, AG Souza, CTG Sares, RB Reis, FP Gallucci, MD Cordeiro, M Pomerantz, GM Lee, ML Freedman, A Jeong, SE Greenberg, A Sanchez, RH Thompson, V Sharma, DD Thiel, CT Ball, D Abreu, ET Lam, WC Nahas, VA Master, AV Patel, JC Bernhard, ND Freedman, P Bigot, RM Reis, LM Colli, A Finelli, BJ Manley, C Terao, TK Choueiri, DM Carraro, R Houlston, JE Eckel-Passow, PH Abbosh, A Ganna, P Brennan, J Gu, SJ Chanock	05/01/2024
Adherence Patterns and Acceptability of a Perioperative, App-Based Mindfulness Meditation Among Surgical Patients With Chronic Pain. The American surgeon	ML Diller, J Mascaro, C Haack, V Master	05/01/2024
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial. European urology	SK Pal, P Grivas, S Gupta, N Dizman, Z Zengin, BP Valderrama, A Rodriguez-Vida, F Roghmann, E Sevillano Fernandez, SF Matin, Y Loriot, SS Sridhar, G Sonpavde, MT Fleming, SP Lerner, J Bellmunt, V Master, A Tripathi, K Davis, D van Veenhuyzen, R Weng, S Daneshmand	04/04/2024
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila. Genetics	JS Brockett, T Manalo, H Zein-Sabatto, J Lee, J Fang, P Chu, H Feng, D Patil, P Davidson, K Ogan, VA Master, JG Pattaras, DL Roberts, SH Bergquist, MA Reyna, JA Petros, DA Lerit, RS Arnold	04/03/2024
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274. European urology oncology	EJ Abel, VA Master, PE Spiess, JD Raman, DD Shapiro, WJ Sexton, L Zemp, D Patil, K Lauer, GO Allen, SF Matin, JA Karam	04/01/2024
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. European urology oncology	EJ Abel, VA Master, PE Spiess, JD Raman, DD Shapiro, WJ Sexton, L Zemp, D Patil, K Lauer, GO Allen, SF Matin, JA Karam	04/01/2024
A Contemporary Clinicopathologic Analysis of Patients With Renal Cell Carcinoma and Vena Cava Involvement. International journal of surgical pathology	OM Al-Rusan, D Patil, VA Master, AO Osunkoya	04/01/2024
Interruptions in bladder cancer care during the COVID-19 public health emergency. Urologic oncology	JL Gore, K Follmer, J Reynolds, M Nash, CB Anderson, JWF Catto, K Chamie, S Daneshmand, R Dickstein, T Garg, SM Gilbert, TJ Guzzo, AM Kamat, MR Kates, BR Lane, Y Lotan, AM Mansour, VA Master, JS Montgomery, DS Morris, KG Nepple, BB O'Neil, S Patel, K Pohar, SP Porten, SB Riggs, A Sankin, KR Scarpato, ND Shore, GD Steinberg, SA Strope, JM Taylor, BA Comstock, LG Kessler, EM Wolff, AB Smith	04/01/2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry. Urologic oncology	C Saitta, JA Afari, A Walia, D Patil, H Tanaka, K Hakimi, L Wang, MF Meagher, F Liu, MV Nguyen, D Puri, C Cerrato, A Saidian, M Kobayashi, S Fukuda, Y Fujii, V Master, IH Derweesh	04/01/2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer	JS Patel, Y Woo, A Draper, CS Jansen, JW Carlisle, PF Innominato, FA Lévi, L Dhabaan, VA Master, MA Bilen, MK Khan, MC Lowe, H Kissick, ZS Buchwald, DC Qian	03/26/2024
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. Cancer	BN Schmeusser, DH Patil, EH Nicaise, M Armas-Phan, R Nabavizadeh, VM Narayan, SS Joshi, K Ogan, AO Osunkoya, MA Bilen, VA Master	02/01/2024
The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers. Biomarker insights	null Seema Mustafa, CS Jansen, Y Jani, S Evans, TZ Zhuang, J Brown, B Nazha, V Master, MA Bilen	01/01/2024
Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma. CA: a cancer journal for clinicians	EH Nicaise, A Yildirim, S Sheth, E Richter, MA Daneshmand, SK Maithel, K Ogan, MA Bilen, VA Master	01/01/2024
Perioperative systemic treatments in renal cell carcinoma. Frontiers in oncology	R Goswamy, E Kalemoglu, V Master, MA Bilen	01/01/2024
AUTHOR REPLY. Urology	BN Schmeusser, EH Nicaise, K Ogan, VA Master	01/01/2024
Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma. Urology	BN Schmeusser, EH Nicaise, AR Palacios, A Ali, DH Patil, M Armas-Phan, K Ogan, VA Master	01/01/2024
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers. Cancer	B Nazha, T Zhuang, S Wu, JT Brown, D Magee, BC Carthon, O Kucuk, C Nabhan, PC Barata, EI Heath, CJ Ryan, RR McKay, VA Master, MA Bilen	12/15/2023
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker. The oncologist	BN Schmeusser, H Biermann, EH Nicaise, AA Ali, DH Patil, E Midenberg, T Helman, M Armas-Phan, R Nabavizadeh, SS Joshi, VM Narayan, MA Bilen, SP Psutka, K Ogan, VA Master	12/11/2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The oncologist	GE Sanda, JM Shabto, S Goyal, Y Liu, DJ Martini, B Nazha, JT Brown, LB Yantorni, G Anne Russler, S Caulfield, SS Joshi, VM Narayan, H Kissick, K Ogan, VA Master, BC Carthon, O Kucuk, MA Bilen	12/11/2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. Journal of the National Cancer Institute	T El Zarif, AH Nassar, GR Pond, TZ Zhuang, V Master, B Nazha, S Niglio, N Simon, AW Hahn, CA Pettaway, SM Tu, N Abdel-Wahab, M Velev, R Flippot, S Buti, M Maruzzo, A Mittra, J Gheeya, Y Yang, PA Rodriguez, D Castellano, G de Velasco, G Roviello, L Antonuzzo, RR McKay, B Vincenzi, A Cortellini, G Hui, A Drakaki, M Glover, AR Khaki, E El-Am, N Adra, TH Mouhieddine, V Patel, A Piedra, A Gernone, NB Davis, H Matthews, MR Harrison, R Kanesvaran, GC Giudice, P Barata, A Farolfi, JL Lee, MI Milowsky, C Stahlfeld, L Appleman, JW Kim, D Freeman, TK Choueiri, PE Spiess, A Necchi, AB Apolo, GP Sonpavde	12/06/2023
Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610. European urology oncology	DD Shapiro, JA Karam, VA Master, WJ Sexton, SF Matin, PE Spiess, EJ Abel	12/01/2023
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. Urology	AR Esdaille, JA Karam, VA Master, PE Spiess, JD Raman, P Sharma, DD Shapiro, A Das, WJ Sexton, L Zemp, D Patil, GO Allen, SF Matin, CG Wood, EJ Abel	12/01/2023
Editorial Comment. The Journal of urology	VA Master, E Nicaise	11/01/2023
Evaluation of a Non-race-based Equation in Predicting Glomerular Filtration Rates Postnephrectomy in a Racially Diverse Cohort. Urology practice	EH Nicaise, BN Schmeusser, DH Patil, K Ogan, VA Master	11/01/2023
Reply by Authors. Urology practice	EH Nicaise, BN Schmeusser, DH Patil, K Ogan, VA Master	11/01/2023
A Contemporary Clinicopathologic Analysis of Primary Sarcomas of the Perinephric Soft Tissue and Hilar Vessels Including a Subset Secondarily Involving the Kidney. International journal of surgical pathology	AN Scheiderer, A Bahrami, VA Master, AO Osunkoya	10/01/2023
A randomized-controlled trial assessing the effect of intraoperative acupuncture on anesthesia-related parameters during gynecological oncology surgery. Journal of cancer research and clinical oncology	E Ben-Arye, I Hirsh, Y Segev, M Grach, V Master, A Eden, N Samuels, N Stein, O Gressel, L Ostrovsky, G Galil, M Schmidt, E Schiff, O Lavie	09/01/2023
Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clinical genitourinary cancer	JH Yuan, H Tanaka, D Patil, K Hakimi, S Soliman, MF Meagher, A Saidian, A Walia, S Dhanji, F Liu, J Afari, M Nguyen, L Wang, Y Yasuda, K Saito, Y Fujii, V Master, IH Derweesh	08/01/2023
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus. Clinical genitourinary cancer	BN Schmeusser, E Midenberg, AR Palacios, AA Ali, DH Patil, M Higgins, R Nabavizadeh, B Croll, M Williams, J Sheehy, B Zheng, VM Narayan, SS Joshi, K Ogan, SP Psutka, MA Bilen, VA Master	08/01/2023
99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor. Clinical nuclear medicine	AA Ali, T Sivathapandi, R Gupta, VA Master, C Marcus	08/01/2023
Barriers and facilitators to physical activity prehabilitation in patients with kidney cancer. European journal of oncology nursing : the official journal of European Oncology Nursing Society	CM Paulo, AA Ali, BN Schmeusser, E Midenberg, TA Helman, ML Diller, MF Pisters, K Ogan, VA Master	08/01/2023
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6. European urology	DD Shapiro, JA Karam, VA Master, LW Zemp, WJ Sexton, SF Matin, PE Spiess, E Jason Abel	08/01/2023
Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma. Current urology reports	BN Schmeusser, AA Ali, FJ Fintelmann, JM Garcia, GR Williams, VA Master, SP Psutka	07/01/2023
The 5-factor frailty index for radical nephrectomy: Simplifying personalized preoperative risk-stratification. Urologic oncology	BN Schmeusser, VA Master	07/01/2023
Prolonged Opioid Use Following Bladder Tumor Resection for Opioid-naïve Patients. Urology practice	B Croll, D Patil, M Mason, VM Narayan, V Master, CP Filson, SS Joshi	07/01/2023
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19. The oncologist	CD Bergerot, J Malhotra, P Bergerot, EJ Philip, DV Castro, J Hsu, ACA Mota, A Cardoso de Azeredo, JNM Neto, T Hutson, V Grünwald, A Bex, SP Psutka, B Rini, ER Plimack, V Master, L Albiges, TK Choueiri, S Pal, T Powles	06/02/2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey. Clinical genitourinary cancer	G Prakash, A Arora, M Bandini, G Basile, M Pal, G Griffiths, R Cornes, Y Zhu, A Rodriguez, M Alberson, A Necchi, V Master, CA Pettaway, PE Spiess	06/01/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	04/01/2023
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. European urology open science	DD Shapiro, JA Karam, L Zemp, VA Master, WJ Sexton, A Ghasemzadeh, BN Schmeusser, F Davaro, T Peak, D Patil, S Matin, PE Spiess, EJ Abel	04/01/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	04/01/2023
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	TZ Zhuang, D Ravindranathan, Y Liu, DJ Martini, JT Brown, B Nazha, G Russler, LB Yantorni, S Caulfield, BC Carthon, O Kucuk, VA Master, MA Bilen	03/17/2023
Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer	BN Schmeusser, AR Palacios, ER Midenberg, R Nabavizadeh, DH Patil, RD Harvey, J Bryksin, MJ Connor, K Ogan, MA Bilen, VA Master	03/15/2023
Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international	MV Nguyen, A Walia, A Saidian, D Puri, MF Meagher, K Hakimi, H Tanaka, D Patil, Y Yasuda, K Saito, S Dhanji, C Cerrato, R Narasimhan, J Perry, V Master, Y Fujii, IH Derweesh	02/01/2023
Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus. Journal of immunotherapy and precision oncology	VA Master, BN Schmeusser, AO Osunkoya, AR Palacios, E Midenberg, L Yantorni, K Ogan, MA Bilen	02/01/2023
Integrative Surgery: Embedding Complementary and Nonpharmacologic Therapies into Surgical Pain Management Strategies. The American surgeon	ML Diller, V Master	02/01/2023
CD8⁺ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity	N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, BG Barwick, C Jansen, A Reyes Moon, P Gregorova, L delBalzo, R Greenwald, MA Bilen, M Alemozaffar, S Joshi, C Cimmino, C Larsen, V Master, M Sanda, H Kissick	01/10/2023
Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma. Journal of kidney cancer and VHL	BN Schmeusser, TA Manalo, Y Liu, YB Shah, A Ali, M Armas-Phan, DH Patil, R Nabavizadeh, K Ogan, VA Master	01/01/2023
Inguinal lymph node dissection in the era of minimally invasive surgical technology. Urologic oncology	R Nabavizadeh, B Petrinec, B Nabavizadeh, A Singh, S Rawal, V Master	01/01/2023
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urologic oncology	E Midenberg, MI Higgins, BN Schmeusser, DH Patil, J Zaldumbide, DJ Martini, S Steele, M Williams, R Nabavizadeh, SP Psutka, K Ogan, MA Bilen, VA Master	01/01/2023
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma. Data in brief	BN Schmeusser, DH Patil, E Midenberg, MI Higgins, J Zaldumbide, DJ Martini, S Steele, M Williams, R Nabavizadeh, SP Psutka, K Ogan, MA Bilen, VA Master	12/01/2022
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JJ Mao, N Ismaila, T Bao, D Barton, E Ben-Arye, EL Garland, H Greenlee, T Leblanc, RT Lee, AM Lopez, C Loprinzi, GH Lyman, J MacLeod, VA Master, K Ramchandran, LI Wagner, EM Walker, DW Bruner, CM Witt, E Bruera	12/01/2022
Resection of retroperitoneal tumors with inferior vena cava involvement without caval reconstruction. Journal of surgical oncology	AR Palacios, BN Schmeusser, E Midenberg, D Patil, L Xie, R Nabavizadeh, K Ogan, K Cardona, SK Maithel, VA Master	12/01/2022
Response to a letter to the editor regarding inferior vena cava ligation. Journal of surgical oncology	BN Schmeusser, AR Palacios, S Maithel, VA Master	12/01/2022
Risk Stratification of Prostatic Adenocarcinoma Metastatic to the Lymph Nodes. Archives of pathology & laboratory medicine	S Bidot, A Monsrud, M Kline, A Speak, D Martini, MA Bilen, JM Switchenko, Y Zhang, AG Gerges, GN Farhat, EA Dent, VA Master, ML Tinsley, LR Harik	11/01/2022
Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma. Translational andrology and urology	ER Midenberg, BN Schmeusser, A Palacios, K Larsen, DH Patil, B Petrinec, B Croll, TL Le, G Hong, FR Lin, K Jesson, G Lee, FY Kwon, K Ogan, VA Master	11/01/2022
Extramammary Paget's disease: Updates in the workup and management. Asian journal of urology	R Nabavizadeh, KB Vashi, B Nabavizadeh, VM Narayan, VA Master	10/01/2022
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Lancet (London, England)	SK Pal, R Uzzo, JA Karam, VA Master, F Donskov, C Suarez, L Albiges, B Rini, Y Tomita, AG Kann, G Procopio, F Massari, M Zibelman, I Antonyan, M Huseni, D Basu, B Ci, W Leung, O Khan, S Dubey, A Bex	10/01/2022
Utility of ultrasonography in preoperative assessment of tumor thrombi in kidney cancer. The Canadian journal of urology	R Nabavizadeh, G Lee, K Bobrek, D Patil, M Alemozaffar, C Moreno, VA Master	10/01/2022
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer	M Toide, K Saito, Y Yasuda, H Tanaka, S Fukuda, D Patil, BH Cotta, SH Patel, VA Master, IH Derweesh, Y Fujii	08/01/2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. Journal of immunotherapy and precision oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, EE Hitron, GA Russler, L Yantorni, S Caulfield, JT Brown, JM Goldman, B Nazha, BC Carthon, WB Harris, O Kucuk, VA Master, MA Bilen	08/01/2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood. Journal for immunotherapy of cancer	JW Carlisle, CS Jansen, MA Cardenas, E Sobierajska, AM Reyes, R Greenwald, L Del Balzo, N Prokhnevska, O Kucuk, BC Carthon, PC Mullane, A Osunkoya, D Baumgarten, F Hosseinzadeh, S Wilkinson, R Lake, AG Sowalsky, Y Liu, VA Master, MA Bilen, H Kissick	07/01/2022
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma. The oncologist	B Nazha, TZ Zhuang, HI Dada, LM Drusbosky, JT Brown, D Ravindranathan, BC Carthon, O Kucuk, J Goldman, VA Master, MA Bilen	06/08/2022
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Cancer	AI Khan, SP Psutka, DH Patil, G Hong, MA Williams, MA Bilen, A Sekhar, HT Kissick, VM Narayan, SS Joshi, K Ogan, VA Master	06/01/2022
How to Care and Minimize the Sequelae of Lower Extremity Lymphedema. Seminars in oncology nursing	K Bobrek, R Nabavizadeh, B Nabavizadeh, V Master	06/01/2022
Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations. Oncology (Williston Park, N.Y.)	D Gentile, D Beeler, XS Wang, E Ben-Arye, SM Zick, T Bao, LE Carlson, R Ghelman, V Master, D Tripathy, WI Zhi	05/09/2022
Autologous Dendritic Vaccine Therapy in Metastatic Kidney Cancer: The ADAPT Trial and Beyond. European urology focus	VA Master, RG Uzzo, G Bratlavsky, JA Karam	05/01/2022
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC). Urology	MF Meagher, D Patil, K Saito, JF Javier-Desloges, AW Bradshaw, SH Patel, BH Cotta, Y Yasuda, A Eldefrawy, F Ghali, R Nasseri, F Wan, Y Fujii, V Master, IH Derweesh	05/01/2022
Dissemination of validated health literacy videos: A tailored approach. Cancer medicine	SM Blee, J Facdol, MD Dixon, V Master, JM Switchenko, RD Pentz	04/01/2022
A global approach to improving penile cancer care. Nature reviews. Urology	M Bandini, M Ahmed, G Basile, N Watkin, V Master, Y Zhu, G Prakash, A Rodriguez, MK Ssebakumba, R Leni, GO Cirulli, B Ayres, R Compitello, F Pederzoli, PM Joshi, SB Kulkarni, F Montorsi, G Sonpavde, A Necchi, PE Spiess	04/01/2022
Author Correction: A global approach to improving penile cancer care. Nature reviews. Urology	M Bandini, M Ahmed, G Basile, N Watkin, V Master, Y Zhu, G Prakash, A Rodriguez, MK Ssebakumba, R Leni, GO Cirulli, B Ayres, R Compitello, F Pederzoli, PM Joshi, SB Kulkarni, F Montorsi, G Sonpavde, A Necchi, PE Spiess	04/01/2022
Extramammary Paget's Disease of genitourinary origin. Current opinion in urology	VM Narayan, VA Master	03/01/2022
Let's ask the patient: Self-reported quality-of-life measures help to predict kidney cancer mortality. Cancer	B Nabavizadeh, VA Master	02/01/2022
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical genitourinary cancer	DJ Martini, ST Evans, Y Liu, JM Shabto, OE Uner, TA Olsen, JT Brown, GA Russler, L Yantorni, S Caulfield, JM Goldman, B Nazha, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	02/01/2022
Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology	C Keiner, M Meagher, D Patil, K Saito, A Walia, F Liu, R Dutt, N Miller, S Dhanji, A Saidian, F Wan, Y Yasuda, Y Fujii, H Tanaka, V Master, I Derweesh	01/01/2022
Case report: Important considerations for a renal mass on a solitary kidney in an adult with history of childhood wilms tumor. Frontiers in oncology	BN Schmeusser, AR Palacios, E Midenberg, R Nabavizadeh, VA Master, SS Joshi	01/01/2022
Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma. Frontiers in oncology	BN Schmeusser, E Midenberg, AR Palacios, N Vettikattu, DH Patil, A Medline, M Higgins, M Armas-Phan, R Nabavizadeh, SS Joshi, VM Narayan, SP Psutka, K Ogan, MA Bilen, VA Master	01/01/2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report. Frontiers in oncology	TZ Zhuang, L Harik, S Force, A Hadadi, MA Bilen, JT Brown, BC Carthon, J Goldman, O Kucuk, VA Master, B Nazha	01/01/2022
Examination of Provider and Patient Knowledge, Beliefs, and Preferences in Integrative Oncology at a National Cancer Institute-Designated Comprehensive Cancer Center. Integrative medicine reports	JS Mascaro, A Catic, M Srivastava, M Diller, S Rana, C Escoffery, V Master	01/01/2022
Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital. Journal of health care for the poor and underserved	A Dong, R Nabavizadeh, JF Jiang, SL Washington, VA Master	01/01/2022
Low free testosterone is associated with increased mortality in frail surgical patients. Surgery open science	F Lin, G Hong, F Kwon, F Pirani, S Makhani, M Henry, I Cooke, R Nabavizadeh, E Midenberg, A Mehta, C Ritenour, VA Master, K Ogan	01/01/2022
Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS). Urologic oncology	K Velaer, IC Thomas, J Yang, K Kapphahn, TJ Metzner, A Golla, CR Hoerner, AC Fan, V Master, GM Chertow, JD Brooks, CJ Patel, M Desai, JT Leppert	01/01/2022
Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage. Cancers	OO Bifarin, DA Gaul, S Sah, RS Arnold, K Ogan, VA Master, DL Roberts, SH Bergquist, JA Petros, AS Edison, FM Fernández	12/13/2021
Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders. Cancer medicine	IJ Cooke, D Patil, K Bobrek, V Narayan, V Master, M Rapaport, CP Filson, SS Joshi	12/01/2021
Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate cancer and prostatic diseases	IM Asiri, RC Chen, HN Young, J Codling, A Mandawat, SRH Beach, V Master, J Rajbhandari-Thapa, EK Cobran	12/01/2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	12/01/2021
Integrative surgical oncology: A model of acute integrative oncology. Cancer	ML Diller, VA Master	11/01/2021
Palliative care use among bladder cancer patients treated with radical cystectomy. Urologic oncology	N Ismaeel, D Patil, M Alemozaffar, CP Filson, VA Master, A Lay	11/01/2021
Left renal vein nutcracker syndrome and concurrent IVC duplication: Surgical treatment. Urology case reports	E Midenberg, R Subu, A Sekhar, B Browne, Y Duwayri, VA Master	11/01/2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, WB Harris, HT Kissick, VA Master, O Kucuk, BC Carthon, MA Bilen	10/01/2021
Impact of radiation therapy on perineal urethrostomy for penile cancer. Clinical and translational radiation oncology	P A S Johnstone, HM de Vries, J Chipollini, G Daniel Grass, F Boyd, F Korkes, M Albersen, E Roussel, Y Zhu, DW Ye, V Master, TL Le, A Muneer, OR Brouwer, PE Spiess	09/01/2021
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC). Clinical genitourinary cancer	SH Patel, IH Derweesh, K Saito, D Patil, MF Meagher, A Bindayi, A Eldefrawy, DN Patel, R Nasseri, Y Yasuda, Y Fujii, VA Master	08/01/2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, FI Tade, SS Joshi, VA Master, B Fielder, RK Halkar, C Zhang, S Goyal, MM Goodman, DM Schuster	08/01/2021
Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial. Urologic oncology	DL Berry, F Hong, TM Blonquist, B Halpenny, N Xiong, CP Filson, VA Master, MG Sanda, P Chang, GW Chien, RA Jones, TL Krupski, S Wolpin, L Wilson, JH Hayes, QD Trinh, M Sokoloff	08/01/2021
Outcomes of perineal urethrostomy for penile cancer: A 20-year international multicenter experience. Urologic oncology	HM de Vries, J Chipollini, J Slongo, F Boyd, F Korkes, M Albersen, E Roussel, Y Zhu, DW Ye, V Master, TL Le, PA Johnstone, A Muneer, OR Brouwer, PE Spiess	08/01/2021
Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics. Journal of proteome research	OO Bifarin, DA Gaul, S Sah, RS Arnold, K Ogan, VA Master, DL Roberts, SH Bergquist, JA Petros, FM Fernández, AS Edison	07/02/2021
Machine Learning in Body Composition Analysis. European urology focus	MI Higgins, JP Marquardt, VA Master, FJ Fintelmann, SP Psutka	07/01/2021
Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. European urology focus	F Pirani, SS Makhani, FY Kim, AH Lay, CB Cimmino, L Hartsell, A Spence, VA Master, K Ogan	07/01/2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer	JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen	07/01/2021
Current practice patterns of society of urologic oncology members in performing inguinal lymph node staging/therapy for penile cancer: A survey study. Urologic oncology	N Marilin, VA Master, CA Pettaway, PE Spiess	07/01/2021
A Helpful Tool in the Renal Surgery Armamentarium: Dorsal Lumbotomy nephrectomy for Tumor in Patients with End-Stage Renal Disease. Urology	I Cooke, S Sadruddin, D Patil, S Tripathi, R Nabavizadeh, S Joshi, V Narayan, K Ogan, VA Master	07/01/2021
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma. Cancer	MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, SS Joshi, VM Narayan, A Sekhar, SP Psutka, K Ogan, MA Bilen, VA Master	06/15/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	05/22/2021
Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009. European urology focus	F Pirani, S Makhani, F Kim, A Lay, C Cimmino, L Hartsell, A Spence, VA Master, K Ogan	05/01/2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen	05/01/2021
What you need to know: updates in penile cancer staging. World journal of urology	MI Khalil, MH Kamel, J Dhillon, V Master, R Davis, AJ Hajiran, PE Spiess	05/01/2021
Inflammatory Markers in Cancer Immunotherapy. Biology	D Ravindranathan, VA Master, MA Bilen	04/13/2021
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos. Journal of visualized experiments : JoVE	S Steele, F Lin, TL Le, A Medline, M Higgins, A Sandberg, S Evans, G Hong, MA Williams, MA Bilen, S Psutka, K Ogan, VA Master	03/21/2021
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC). BJU international	BH Cotta, MF Meagher, D Patil, K Saito, SH Patel, DN Patel, N Miller, R Dutt, C Keiner, AW Bradshaw, F Wan, A Eldefrawy, Y Yasuda, Y Fujii, V Master, IH Derweesh	03/01/2021
Who really knows the performance status: The physician or the patient? Cancer	MI Higgins, VA Master	02/01/2021
Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case Controlled Study. The Journal of urology	L Xie, G Hong, R Nabavizadeh, D Patil, CG Ethun, K Ogan, SK Maithel, VA Master	02/01/2021
EDITORIAL COMMENT. Urology	R Nabavizadeh, MI Higgins, VA Master, K Ogan	02/01/2021
Overlapping Urological Surgeries at a Tertiary Academic Center. Urology	R Nabavizadeh, MI Higgins, D Patil, KC Biebighauser Bens, E Traorè, VA Master, K Ogan	02/01/2021
Health literacy and shared decision making in prostate cancer screening: Equality versus equity. Cancer	SL Washington, VA Master	01/15/2021
Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations. Oncology (Williston Park, N.Y.)	WI Zhi, D Gentile, M Diller, A Kinney, T Bao, V Master, XS Wang	01/11/2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications	DJ Martini, MR Kline, Y Liu, JM Shabto, BC Carthon, GA Russler, L Yantorni, EE Hitron, S Caulfield, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen	01/01/2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, HT Kissick, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	01/01/2021
Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma. Frontiers in oncology	DJ Martini, CS Jansen, LR Harik, ST Evans, TA Olsen, VA Master, HT Kissick, MA Bilen	01/01/2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in oncology	TA Olsen, DJ Martini, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, WB Harris, O Kucuk, BC Carthon, VA Master, B Nazha, MA Bilen	01/01/2021
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (¹⁸F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International journal of radiation oncology, biology, physics	A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, V Master, SS Joshi, O Kucuk, B Carthon, MA Bilen, S Cooper, B Fielder, O Abiodun-Ojo, VR Dhere, DM Schuster	12/01/2020
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma. Urology	LD Dreyfuss, VA Master, JD Raman, PE Spiess, SA Wells, SB Merrill, CC Peyton, D Sankar, B Sohl, D Patil, DD Shapiro, GO Allen, EJ Abel	12/01/2020
Quantification of body composition in renal cell carcinoma patients: Comparing computed tomography and magnetic resonance imaging measurements. European journal of radiology	MI Higgins, DJ Martini, DH Patil, S Steele, S Evans, BP Petrinec, SP Psutka, A Sekhar, MA Bilen, VA Master	11/01/2020
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes. Annals of transplantation	R Nabavizadeh, AA Noorali, SS Makhani, G Hong, S Holzman, DH Patil, FY Kim, PL Tso, NA Turgeon, K Ogan, VA Master	10/23/2020
Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis. International journal of urology : official journal of the Japanese Urological Association	RC Obeng, RS Arnold, K Ogan, VA Master, JG Pattaras, JA Petros, AO Osunkoya	09/01/2020
Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation. Urologic oncology	R Nabavizadeh, K Bobrek, VA Master	09/01/2020
Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer. Journal of clinical medicine	R Nabavizadeh, B Petrinec, A Necchi, I Tsaur, M Albersen, V Master	08/03/2020
A Rare Case of Vena Cava Tumor Thrombus Associated With Epithelioid Angiomyolipoma. Urology	G Lee, R Nabavizadeh, AO Osunkoya, VA Master	08/01/2020
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer. Cancer	DJ Martini, Y Liu, VA Master, RD Harvey, MA Bilen	07/01/2020
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma. Urology	D Patil, TL Le, KB Bens, M Alemozaffar, A Lay, J Pattaras, CP Filson, K Ogan, MA Bilen, VA Master	07/01/2020
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	RA Figlin, NM Tannir, RG Uzzo, SS Tykodi, DYT Chen, V Master, A Kapoor, D Vaena, W Lowrance, G Bratslavsky, M DeBenedette, A Gamble, A Plachco, MS Norris, J Horvatinovich, IY Tcherepanova, CA Nicolette, CG Wood	05/15/2020
In Reply. The oncologist	MA Bilen, VA Master, RD Harvey	05/01/2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine	JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	04/01/2020
Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer	H Fukushima, K Saito, Y Yasuda, H Tanaka, D Patil, BH Cotta, SH Patel, VA Master, IH Derweesh, Y Fujii	04/01/2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The oncologist	MA Bilen, DJ Martini, Y Liu, JM Shabto, JT Brown, M Williams, AI Khan, A Speak, C Lewis, H Collins, HT Kissick, BC Carthon, M Akce, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master	03/01/2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, Y Liu, JM Shabto, BC Carthon, EE Hitron, GA Russler, S Caulfield, HT Kissick, WB Harris, O Kucuk, VA Master, MA Bilen	03/01/2020
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer	DJ Martini, MR Kline, Y Liu, JM Shabto, MA Williams, AI Khan, C Lewis, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master, MA Bilen	02/01/2020
Multidisciplinary Care of Adult Wilms' Tumor During Pregnancy: A Case Report and Review of the Literature. Clinical genitourinary cancer	JT Brown, LR Harik, MS Barbee, N Esiashvili, ML Badell, KC Goldsmith, VA Master, MA Bilen	02/01/2020
Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital. The Journal of urology	JF Jiang, AK Leung, B Pettitt-Schieber, R Nabavizadeh, RL Thomas, M Brown, D Hafford, AH Lay, J Hammett, KJ Carney, CP Filson, VA Master	02/01/2020
Reply by Authors. The Journal of urology	JF Jiang, AK Leung, B Pettitt-Schieber, R Nabavizadeh, RL Thomas, M Brown, D Hafford, AH Lay, J Hammett, KJ Carney, CP Filson, VA Master	02/01/2020
The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy. European urology focus	CC Peyton, EJ Abel, J Chipollini, DC Boulware, M Azizi, JA Karam, V Margulis, VA Master, SF Matin, JD Raman, WJ Sexton, CG Wood, PE Spiess	01/15/2020
Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis. Asian journal of urology	D Laganosky, CP Filson, D Patil, VA Master	01/01/2020
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report. Frontiers in oncology	MA Bilen, JF Jiang, CS Jansen, JT Brown, LR Harik, A Sekhar, H Kissick, SK Maithel, O Kucuk, B Carthon, VA Master	01/01/2020
The immunosuppressive phenotype of tumor-infiltrating neutrophils is associated with obesity in kidney cancer patients. Oncoimmunology	C Margaroli, MA Cardenas, CS Jansen, A Moon Reyes, F Hosseinzadeh, G Hong, Y Zhang, H Kissick, R Tirouvanziam, VA Master	01/01/2020
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. Investigational new drugs	DJ Martini, Y Liu, JM Shabto, C Lewis, MR Kline, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, VA Master, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, MA Bilen	12/01/2019
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature	CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, M Cardenas, S Wilkinson, R Lake, AG Sowalsky, RM Valanparambil, WH Hudson, D McGuire, K Melnick, AI Khan, K Kim, YM Chang, A Kim, CP Filson, M Alemozaffar, AO Osunkoya, P Mullane, C Ellis, R Akondy, SJ Im, AO Kamphorst, A Reyes, Y Liu, H Kissick	12/01/2019
Videos improve patient understanding of misunderstood chemotherapy terminology. Cancer	RD Pentz, M Lohani, M Hayban, JM Switchenko, MD Dixon, RJ DeFeo, GM Orloff, AB Jani, VA Master	11/15/2019
A Preoperative Cognitive Screening Test Predicts Increased Length of Stay in a Frail Population: A Retrospective Case-Control Study. Anesthesia and analgesia	VN O'Reilly-Shah, S Hemani, P Davari, L Glowka, E Gebhardt, L Hill, S Lee, VA Master, AD Rodriguez, PS García	11/01/2019
¹⁸F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AA Akintayo, OO Akin-Akintayo, FI Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, B Fei, DM Schuster	11/01/2019
Optimizing cystectomy outcomes. Cancer	SP Porten, VA Master	10/15/2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology	J González, JJ Gaynor, JI Martínez-Salamanca, U Capitanio, D Tilki, JA Carballido, V Chantada, S Daneshmand, CP Evans, C Gasch, P Gontero, A Haferkamp, WC Huang, EL Espinós, VA Master, JM McKiernan, F Montorsi, S Pahernik, J Palou, RS Pruthi, O Rodriguez-Faba, P Russo, DS Scherr, SF Shariat, M Spahn, C Terrone, C Vera-Donoso, R Zigeuner, M Hohenfellner, JA Libertino, G Ciancio	10/01/2019
A randomized, controlled trial for transurethral treatment of bladder tumors using PlasmaButton vaporization electrode or monopolar loop electrocautery. The Canadian journal of urology	M Alemozaffar, K Ogan, CP Filson, D Patil, G Lee, DJ Canter, G Hong, VA Master	10/01/2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC cancer	MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, H Kissick, BC Carthon, WL Shaib, OB Alese, CE Steuer, C Wu, DH Lawson, R Kudchadkar, VA Master, B El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey	08/29/2019
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	AI Khan, DA Reiter, A Sekhar, P Sharma, NM Safdar, DH Patil, SP Psutka, WC Small, MA Bilen, K Ogan, VA Master	08/01/2019
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer. The Journal of urology	B Fei, OA Abiodun-Ojo, AA Akintayo, O Akin-Akintayo, F Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, DM Schuster	08/01/2019
Avoiding the Need for Bowel Anastomosis during Pelvic Exenteration-Urinary Sigmoid or Descending Colon Conduit-Short and Long Term Complications. Urology	M Alemozaffar, CS Nam, MA Said, D Patil, KJ Carney, S David, VA Master	07/01/2019
Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy. Clinical genitourinary cancer	MA Taylor, M Alemozaffar, VA Master, MG Sanda, CP Filson	06/01/2019
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER? Future oncology (London, England)	HD Patel, M Puligandla, BM Shuch, BC Leibovich, A Kapoor, VA Master, CG Drake, DY Heng, PN Lara, TK Choueiri, D Maskens, EA Singer, SE Eggener, RS Svatek, WM Stadler, S Cole, S Signoretti, RT Gupta, MD Michaelson, DF McDermott, D Cella, LI Wagner, NB Haas, MA Carducci, LC Harshman, ME Allaf	05/01/2019
Minimally invasive approaches to the inguinal nodes in cN0 patients. Current opinion in urology	R Nabavizadeh, V Master	03/01/2019
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support. Urology practice	DL Berry, F Hong, B Halpenny, MG Sanda, VA Master, CP Filson, P Chang, GW Chien, M Underhill, E Fox, J McReynolds, S Wolpin	03/01/2019
Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis. BMC medical informatics and decision making	LS Wilson, TM Blonquist, F Hong, B Halpenny, S Wolpin, P Chang, CP Filson, VA Master, MG Sanda, GW Chien, RA Jones, TL Krupski, DL Berry	01/09/2019
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation. American journal of clinical oncology	J Zhong, J Switchenko, NK Jegadeesh, RJ Cassidy, TW Gillespie, V Master, P Nieh, M Alemozaffar, O Kucuk, B Carthon, CP Filson, MA Bilen, AB Jani	01/01/2019
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer	MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, VA Master, SS Ramalingam, TK Owonikoko, RD Harvey	01/01/2019
The value of a cross-discipline team-based approach for resection of renal cell carcinoma with IVC tumor thrombus: A report of a large, contemporary, single-institution experience. Journal of surgical oncology	VA Master, CG Ethun, DA Kooby, CA Staley, SK Maithel	12/01/2018
Role of metastasis-directed treatment in kidney cancer. Cancer	SP Psutka, VA Master	09/15/2018
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients. European urology oncology	SP Psutka, DA Barocas, JWF Catto, JL Gore, CT Lee, TM Morgan, VA Master, A Necchi, M Rouprêt, SA Boorjian	09/01/2018
Editorial Comment. The Journal of urology	V Master	09/01/2018
Author Reply. Urology	AK Leung, KA Moses, VA Master	07/01/2018
The Clinical Course of Patients With Prostate-Specific Antigen ≥100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening. Urology	AK Leung, L Hugar, D Patil, L Wong, B Carthon, KJ Carney, G Birdsong, KA Moses, VA Master	07/01/2018
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clinical genitourinary cancer	MA Bilen, GMA Dutcher, Y Liu, D Ravindranathan, HT Kissick, BC Carthon, O Kucuk, WB Harris, VA Master	06/01/2018
Editorial Comment. The Journal of urology	V Master	06/01/2018
Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European journal of radiology	O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, R Halkar, B Fei, V Master, AB Jani, H Kitajima, AO Osunkoya, C Ormenisan-Gherasim, MM Goodman, DM Schuster	05/01/2018
The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology	R Hutchinson, C Rew, G Chen, S Woldu, LM Krabbe, M Meissner, K Sheth, N Singla, N Shakir, VA Master, JA Karam, SF Matin, LD Borregales, C Wood, T Masterson, RH Thompson, SA Boorjian, BC Leibovich, EJ Abel, A Bagrodia, V Margulis	05/01/2018
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Clinical genitourinary cancer	J Chipollini, EJ Abel, CC Peyton, DC Boulware, JA Karam, V Margulis, VA Master, K Zargar-Shoshtari, SF Matin, WJ Sexton, JD Raman, CG Wood, PE Spiess	04/01/2018
A semiautomatic algorithm for three-dimensional segmentation of the prostate on CT images using shape and local texture characteristics. Proceedings of SPIE--the International Society for Optical Engineering	M Shahedi, L Ma, M Halicek, R Guo, G Zhang, DM Schuster, P Nieh, V Master, B Fei	02/01/2018
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Urologic oncology	D Tilki, T Chandrasekar, U Capitanio, G Ciancio, S Daneshmand, P Gontero, J Gonzalez, A Haferkamp, M Hohenfellner, WC Huang, E Linares Espinós, A Lorentz, JI Martinez-Salamanca, VA Master, JM McKiernan, F Montorsi, G Novara, S Pahernik, J Palou, RS Pruthi, O Rodriguez-Faba, P Russo, DS Scherr, SF Shariat, M Spahn, C Terrone, C Vera-Donoso, R Zigeuner, JA Libertino, CP Evans	02/01/2018
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma. Oncoimmunology	KS Kim, RR Sekar, D Patil, MA Dimarco, HT Kissick, MA Bilen, AO Osunkoya, VA Master	01/01/2018
Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial. The Journal of urology	DL Berry, F Hong, TM Blonquist, B Halpenny, CP Filson, VA Master, MG Sanda, P Chang, GW Chien, RA Jones, TL Krupski, S Wolpin, L Wilson, JH Hayes, QD Trinh, M Sokoloff, P Somayaji	01/01/2018
Paraneoplastic Thrombocytopenia Cured With Nephrectomy and Vena Cava Thrombectomy: Concurrent Hematology and Oncology Management Conundrums. Journal of oncology practice	KR Melnick, C Chang, A Antun, SK Maithel, VA Master	11/01/2017
Cognitive Impairment and Overall Survival in Frail Surgical Patients. Journal of the American College of Surgeons	SS Makhani, FY Kim, Y Liu, Z Ye, JL Li, LM Revenig, CP Vaughan, TM Johnson, PS García, K Ogan, VA Master	11/01/2017
A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial. Annals of surgical oncology	LM Postlewait, CR Farley, ML Diller, B Martin, M Hart Squires, MC Russell, M Rizzo, K Ogan, V Master, K Delman	10/01/2017
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology	RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master	10/01/2017
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus. The Journal of urology	EJ Abel, TA Masterson, JA Karam, VA Master, V Margulis, R Hutchinson, CA Lorentz, E Bloom, TM Bauman, CG Wood, ML Blute	10/01/2017
Technical considerations to minimize complications of inguinal lymph node dissection. Translational andrology and urology	MK Gupta, AP Patel, VA Master	10/01/2017
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. CA: a cancer journal for clinicians	CG Ethun, MA Bilen, AB Jani, SK Maithel, K Ogan, VA Master	09/01/2017
Patient Frailty and Discharge Disposition Following Radical Cystectomy. Clinical genitourinary cancer	JA Pearl, D Patil, CP Filson, S Arya, M Alemozaffar, VA Master, K Ogan	08/01/2017
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus. The Journal of urology	EJ Abel, PE Spiess, V Margulis, VA Master, M Mann, K Zargar-Shoshtari, LD Borregales, WJ Sexton, D Patil, SF Matin, CG Wood, JA Karam	08/01/2017
Contemporary management of patients with penile cancer and lymph node metastasis. Nature reviews. Urology	A Leone, GJ Diorio, C Pettaway, V Master, PE Spiess	06/01/2017
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master	06/01/2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. Urologic oncology	RS Gerhard, D Patil, Y Liu, K Ogan, M Alemozaffar, AB Jani, ON Kucuk, VA Master, TW Gillespie, CP Filson	05/01/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	03/01/2017
The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer. Cancer	N Jegadeesh, Y Liu, C Zhang, J Zhong, RJ Cassidy, T Gillespie, O Kucuk, P Rossi, VA Master, M Alemozaffar, AB Jani	02/01/2017
Molecular imaging and fusion targeted biopsy of the prostate. Clinical and translational imaging	B Fei, PT Nieh, VA Master, Y Zhang, AO Osunkoya, DM Schuster	02/01/2017
Automatic segmentation of the prostate on CT images using deep learning and multi-atlas fusion. Proceedings of SPIE--the International Society for Optical Engineering	L Ma, R Guo, G Zhang, F Tade, DM Schuster, P Nieh, V Master, B Fei	02/01/2017
Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States. Urology	SA David, D Patil, M Alemozaffar, MM Issa, VA Master, CP Filson	02/01/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. Clinical nuclear medicine	OO Akin-Akintayo, AB Jani, O Odewole, FI Tade, PT Nieh, VA Master, LM Bellamy, RK Halkar, C Zhang, Z Chen, MM Goodman, DM Schuster	01/01/2017
Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma. Current urology reports	DD Laganosky, CP Filson, VA Master	01/01/2017
Role of Imaging in the Evaluation of Male Infertility. Radiographics : a review publication of the Radiological Society of North America, Inc	PK Mittal, B Little, PA Harri, FH Miller, LF Alexander, B Kalb, JC Camacho, V Master, M Hartman, CC Moreno	01/01/2017
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. Journal of surgical oncology	R Mager, S Daneshmand, CP Evans, J Palou, JI Martínez-Salamanca, VA Master, JM McKiernan, JA Libertino, A Haferkamp, A Haferkamp, U Capitanio, JA Carballido, V Chantada, T Chromecki, G Ciancio, S Daneshmand, CP Evans, P Gontero, J González, M Hohenfellner, WC Huang, TM Koppie, JA Libertino, EL Espinós, A Lorentz, JI Martínez-Salamanca, VA Master, JM McKiernan, F Montorsi, G Novara, P O'Malley, S Pahernik, J Palou, JL Moreno, RS Pruthi, OR Faba, P Russo, DS Scherr, SF Shariat, M Spahn, C Terrone, D Tilki, D Vázquez-Martul, CV Donoso, D Vergho, EM Wallen, R Zigeuner	11/01/2016
Surgical Management of Primary Scrotal Cancer. The Urologic clinics of North America	JH Huang, M Broggi, AO Osunkoya, VA Master	11/01/2016
Author Reply. Urology	MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, VA Master	10/01/2016
Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Urology	MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, VA Master	10/01/2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European journal of nuclear medicine and molecular imaging	OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, PJ Rossi, RK Halkar, AO Osunkoya, O Akin-Akintayo, C Zhang, Z Chen, MM Goodman, DM Schuster	09/01/2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. International journal of radiation oncology, biology, physics	BC Baumann, WR Bosch, A Bahl, AJ Birtle, RH Breau, A Challapalli, AJ Chang, A Choudhury, S Daneshmand, A El-Gayed, A Feldman, SE Finkelstein, TJ Guzzo, S Hilman, A Jani, SB Malkowicz, CA Mantz, V Master, AV Mitra, V Murthy, SP Porten, PM Richaud, P Sargos, JA Efstathiou, LJ Eapen, JP Christodouleas	09/01/2016
Frailty and one-year mortality in major intra-abdominal operations. The Journal of surgical research	JL Li, MA Henderson, LM Revenig, JF Sweeney, DA Kooby, SK Maithel, VA Master, K Ogan	06/15/2016
Safety and Efficacy of Ureteral Stent Placement at the Bedside Using Local Anesthesia. The Journal of urology	P Nourparvar, A Leung, AB Shrewsberry, AD Weiss, D Patil, H Atallah, K Ogan, KJ Carney, VA Master	06/01/2016
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival. Asian journal of urology	RR Sekar, CM De La Calle, D Patil, SA Holzman, Y Baum, U Sheikh, JH Huang, AO Osunkoya, BP Pollack, HT Kissick, K Ogan, VA Master	04/01/2016
Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes. Clinical genitourinary cancer	BL Harlow, Z Klaassen, S Holzman, L Reinstatler, AA Franken, SK Kavuri, MK Terris, VA Master, KA Moses	04/01/2016
Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases. Human pathology	IU Nwadei, A Lorentz, D Patil, MA Dimarco, VA Master, AO Osunkoya	03/01/2016
The importance of surgical margins in renal cell and urothelial carcinomas. Journal of surgical oncology	M Alemozaffar, CP Filson, VA Master	03/01/2016
Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images. Proceedings of SPIE--the International Society for Optical Engineering	L Ma, R Guo, Z Tian, R Venkataraman, S Sarkar, X Liu, PT Nieh, VV Master, DM Schuster, B Fei	02/27/2016
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy. Asian journal of urology	YS Baum, D Patil, JH Huang, S Spetka, M Torlak, PT Nieh, M Alemozaffar, K Ogan, VA Master	01/01/2016
Hematospermia Evaluation at MR Imaging. Radiographics : a review publication of the Radiological Society of North America, Inc	PK Mittal, JC Camacho, DV Sahani, B Kalb, PA Harri, V Master, N Kokabi, M Hartman, HD Kitajima, CC Moreno	01/01/2016
C-reactive protein in urologic cancers. Molecular aspects of medicine	J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master	11/01/2015
Predicting Length of Stay Following Radical Nephrectomy Using the National Surgical Quality Improvement Program Database. The Journal of urology	CA Lorentz, AK Leung, AB DeRosa, SD Perez, TV Johnson, JF Sweeney, VA Master	10/01/2015
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis. The Journal of urology	HG Nguyen, D Tilki, MA Dall'Era, B Durbin-Johnson, JA Carballido, T Chandrasekar, T Chromecki, G Ciancio, S Daneshmand, P Gontero, J Gonzalez, A Haferkamp, M Hohenfellner, WC Huang, EL Espinós, P Mandel, JI Martinez-Salamanca, VA Master, JM McKiernan, F Montorsi, G Novara, S Pahernik, J Palou, RS Pruthi, O Rodriguez-Faba, P Russo, DS Scherr, SF Shariat, M Spahn, C Terrone, D Vergho, EM Wallen, E Xylinas, R Zigeuner, JA Libertino, CP Evans	08/01/2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. The Canadian journal of urology	N Fatima, DJ Canter, BC Carthon, O Kucuk, VA Master, PT Nieh, K Ogan, AO Osunkoya	06/01/2015
Extramammary Paget's disease in males: survival outcomes in 495 patients. Annals of surgical oncology	LA Herrel, AD Weiss, M Goodman, TV Johnson, AO Osunkoya, KA Delman, VA Master	05/01/2015
Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality. Journal of the American College of Surgeons	LM Revenig, DJ Canter, S Kim, Y Liu, JF Sweeney, JM Sarmiento, DA Kooby, SK Maithel, LL Hill, VA Master, K Ogan	05/01/2015
R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. Journal of vascular and interventional radiology : JVIR	JC Camacho, N Kokabi, M Xing, VA Master, JG Pattaras, PK Mittal, HS Kim	05/01/2015
Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics	K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk	04/15/2015
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis. Molecular imaging and biology	OA Odewole, OA Oyenuga, F Tade, B Savir-Baruch, PT Nieh, V Master, Z Chen, X Wang, AB Jani, LM Bellamy, RK Halkar, MM Goodman, DM Schuster	04/01/2015
Video-based educational tool improves patient comprehension of common prostate health terminology. Cancer	DS Wang, AB Jani, M Sesay, CG Tai, DK Lee, KV Echt, MG Goodman, KE Kilbridge, VA Master	03/01/2015
Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association	W Hsiao, LA Herrel, C Yu, MW Kattan, DJ Canter, BC Carthon, K Ogan, VA Master	03/01/2015
Outcomes data in pain studies: in reply to Barbul and colleagues. Journal of the American College of Surgeons	VA Master, AA Watkins, TV Johnson, AB Shrewsberry, P Nourparvar, T Madni, CJ Watkins, PL Feingold, DA Kooby, SK Maithel, CA Staley	03/01/2015
Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer. Journal of the National Comprehensive Cancer Network : JNCCN	RG Quek, KC Ward, VA Master, CC Lin, KM Portier, KS Virgo, J Lipscomb	03/01/2015
Preoperative quantification of perceptions of surgical frailty. The Journal of surgical research	LM Revenig, DJ Canter, MA Henderson, K Ogan, DA Kooby, SK Maithel, Y Liu, S Kim, VA Master	02/01/2015
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. The Journal of urology	D Tilki, B Hu, HG Nguyen, MA Dall'Era, R Bertini, JA Carballido, T Chandrasekar, T Chromecki, G Ciancio, S Daneshmand, P Gontero, J Gonzalez, A Haferkamp, M Hohenfellner, WC Huang, TM Koppie, E Linares, CA Lorentz, P Mandel, JI Martinez-Salamanca, VA Master, R Matloob, JM McKiernan, CM Mlynarczyk, F Montorsi, G Novara, S Pahernik, J Palou, RS Pruthi, K Ramaswamy, O Rodriguez Faba, P Russo, SF Shariat, M Spahn, C Terrone, W Thieu, D Vergho, EM Wallen, E Xylinas, R Zigeuner, JA Libertino, CP Evans	02/01/2015
Surgery for high-risk prostate cancer and metastatic prostate cancer. Current problems in cancer	IJ Safir, F Lian, M Alemozaffar, VA Master	01/01/2015
Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results. Journal for immunotherapy of cancer	A Amin, AZ Dudek, TF Logan, RS Lance, JM Holzbeierlein, JJ Knox, VA Master, SK Pal, WH Miller, LI Karsh, IY Tcherepanova, MA DeBenedette, WL Williams, DC Plessinger, CA Nicolette, RA Figlin	01/01/2015
Testicular tumors: what radiologists need to know--differential diagnosis, staging, and management. Radiographics : a review publication of the Radiological Society of North America, Inc	C Coursey Moreno, WC Small, JC Camacho, V Master, N Kokabi, M Lewis, M Hartman, PK Mittal	01/01/2015
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis. Urologia internationalis	SA Holzman, CM de la Calle, HT Kissick, AO Osunkoya, BP Pollack, D Patil, K Ogan, VA Master	01/01/2015
von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry. The Journal of urology	F Lian, S Sreedharan, RS Arnold, VA Master, K Ogan, JG Pattaras, DL Roberts, JA Petros	11/01/2014
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European urology	D Tilki, HG Nguyen, MA Dall'Era, R Bertini, JA Carballido, T Chromecki, G Ciancio, S Daneshmand, P Gontero, J Gonzalez, A Haferkamp, M Hohenfellner, WC Huang, TM Koppie, CA Lorentz, P Mandel, JI Martinez-Salamanca, VA Master, R Matloob, JM McKiernan, CM Mlynarczyk, F Montorsi, G Novara, S Pahernik, J Palou, RS Pruthi, K Ramaswamy, O Rodriguez Faba, P Russo, SF Shariat, M Spahn, C Terrone, D Vergho, EM Wallen, E Xylinas, R Zigeuner, JA Libertino, CP Evans	09/01/2014
Ice packs reduce postoperative midline incision pain and narcotic use: a randomized controlled trial. Journal of the American College of Surgeons	AA Watkins, TV Johnson, AB Shrewsberry, P Nourparvar, T Madni, CJ Watkins, PL Feingold, DA Kooby, SK Maithel, CA Staley, VA Master	09/01/2014
Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer. Urologic oncology	RG Quek, VA Master, KM Portier, KC Ward, CC Lin, KS Virgo, J Lipscomb	08/01/2014
Leaning in to understand hospital readmission. The Journal of urology	VA Master	07/01/2014
Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009. American journal of public health	J Li, HK Weir, MA Jim, SM King, R Wilson, VA Master	06/01/2014
Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. The Journal of urology	SC King, LA Pollack, J Li, JB King, VA Master	06/01/2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of urology	DM Schuster, PT Nieh, AB Jani, R Amzat, FD Bowman, RK Halkar, VA Master, JA Nye, OA Odewole, AO Osunkoya, B Savir-Baruch, P Alaei-Taleghani, MM Goodman	05/01/2014
A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery. Journal of endourology	LM Revenig, DJ Canter, VA Master, SK Maithel, DA Kooby, JG Pattaras, C Tai, K Ogan	04/01/2014
Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma. Journal of the American College of Surgeons	BM Martin, JW Etra, MC Russell, M Rizzo, DA Kooby, CA Staley, VA Master, KA Delman	04/01/2014
Designing an ethics curriculum to support global health experiences in surgery. The Journal of surgical research	BM Martin, TP Love, J Srinivasan, J Sharma, B Pettitt, C Sullivan, J Pattaras, VA Master, LP Brewster	04/01/2014
Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clinical transplantation	AB Shrewsberry, AO Osunkoya, K Jiang, R Westby, D Canter, J Pattaras, N Turgeon, VA Master, K Ogan	02/01/2014
Evaluation and management of patients with nocturia. JAAPA : official journal of the American Academy of Physician Assistants	SA Easterling, V Master, KJ Carney	02/01/2014
Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions. Disease markers	S Sreedharan, JA Petros, VA Master, K Ogan, JG Pattaras, DL Roberts, F Lian, RS Arnold	01/01/2014
External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India	CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master	01/01/2014
Numeracy among trainees: are we preparing physicians for evidence-based medicine? Journal of surgical education	TV Johnson, A Abbasi, ED Schoenberg, R Kellum, LD Speake, C Spiker, A Foust, A Kreps, CW Ritenour, OW Brawley, VA Master	01/01/2014
Digging deep: high output heart failure in renal cell carcinoma. The American journal of medicine	S Hayek, R Kung, I Barb, V Master, S Al, S Clements	01/01/2014
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer. Cancer	RG Quek, VA Master, KC Ward, CC Lin, KS Virgo, KM Portier, J Lipscomb	10/15/2013
Videoscopic inguinal lymphadenectomy for metastatic melanoma. Cancer control : journal of the Moffitt Cancer Center	BM Martin, VA Master, KA Delman	10/01/2013
Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. Journal of the American College of Surgeons	LM Revenig, DJ Canter, MD Taylor, C Tai, JF Sweeney, JM Sarmiento, DA Kooby, SK Maithel, VA Master, K Ogan	10/01/2013
Minimizing morbidity in melanoma surgery. Oncology (Williston Park, N.Y.)	BM Martin, VA Master, KA Delman	10/01/2013
Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database. The Canadian journal of urology	DJ Canter, K Mallin, RG Uzzo, BL Egleston, J Simhan, J Walton, MC Smaldone, VA Master, G Bratslavsky, A Kutikov	10/01/2013
The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. Cancer	WA Hall, DC Nickleach, VA Master, RS Prabhu, PJ Rossi, K Godette, S Cooper, AB Jani	09/15/2013
Severe lack of comprehension of common prostate health terms among low-income inner-city men. Cancer	DS Wang, AB Jani, CG Tai, M Sesay, DK Lee, M Goodman, KV Echt, KE Kilbridge, VA Master	09/01/2013
Inherent difficulties of measuring the burden of surgical disease in resource-poor settings. World journal of surgery	IL Leeds, LA Hugar, CA Lorentz, J Srinivasan, JG Pattaras, VA Master	09/01/2013
International surgical clerkship rotation: perceptions and academic performance. American journal of surgery	IL Leeds, LA Hugar, BJ Pettitt, J Srinivasan, VA Master	08/01/2013
Racial disparities in prostate cancer care: is adherence to National Comprehensive Cancer Network guidelines good enough for our patients? Cancer	VA Master, KA Moses	06/15/2013
Scrotal cancer survival is influenced by histology: a SEER study. World journal of urology	TV Johnson, W Hsiao, KA Delman, DJ Canter, VA Master	06/01/2013
Chromophobe renal cell carcinoma with sarcomatoid differentiation: a clinicopathologic study of 14 cases. Analytical and quantitative cytopathology and histopathology	SR Lauer, M Zhou, VA Master, AO Osunkoya	04/01/2013
Computed tomography based renal parenchyma volume measurements prior to renal tumor surgery are predictive of postoperative renal function. The Canadian journal of urology	B Kunzel, W Small, M Goodman, J Pattaras, V Master, K Ogan	04/01/2013
Accuracy Evaluation of a 3D Ultrasound-guided Biopsy System. Proceedings of SPIE--the International Society for Optical Engineering	WJ Wooten, JA Nye, DM Schuster, PT Nieh, VA Master, JR Votaw, B Fei	03/14/2013
A win for all: faculty-student partnerships in surgical humanitarianism. Bulletin of the American College of Surgeons	IL Leeds, J Srinivasan, JG Pattaras, VA Master	02/01/2013
Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. The Journal of urology	X Yang, C Shao, R Wang, CY Chu, P Hu, V Master, AO Osunkoya, HL Kim, HE Zhau, LWK Chung	02/01/2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. American journal of nuclear medicine and molecular imaging	DM Schuster, PA Taleghani, PT Nieh, VA Master, R Amzat, B Savir-Baruch, RK Halkar, T Fox, AO Osunkoya, CS Moreno, JA Nye, W Yu, B Fei, Z Wang, Z Chen, MM Goodman	01/01/2013
Breakage of Needle during Intracavernosal Injection and Use of Portable Ultrasound Guidance for Removal. Case reports in urology	W Hsiao, F Lian, B Goodgame, CW Ritenour, J Angell, VA Master	01/01/2013
PET-directed, 3D Ultrasound-guided prostate biopsy. Diagnostic imaging Europe	B Fei, PT Nieh, DM Schuster, VA Master	01/01/2013
Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications. The Journal of urology	VA Master, SM Jafri, KA Moses, K Ogan, DA Kooby, KA Delman	10/01/2012
Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma. The Canadian journal of urology	DJ Canter, RW Dobbs, SM Jafri, LA Herrel, K Ogan, KA Delman, VA Master	08/01/2012
Hyperspectral imaging and quantitative analysis for prostate cancer detection. Journal of biomedical optics	H Akbari, LV Halig, DM Schuster, A Osunkoya, V Master, PT Nieh, GZ Chen, B Fei	07/01/2012
Prospective pilot study of smoking cessation in patients undergoing urologic surgery. Urology	B Kunzel, J Cabalza, M Faurot, T Solomon, P Nieh, J Pattaras, VA Master, K Ogan	07/01/2012
Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach. The Canadian journal of urology	LA Herrel, RM Butterworth, SM Jafri, C Ying, KA Delman, DA Kooby, KE Ogan, DJ Canter, VA Master	06/01/2012
Re: Lymphangiography with sclerotherapy: a novel therapy for refractory chylous ascites. The Canadian journal of urology	VA Master	06/01/2012
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psycho-oncology	TV Johnson, SJ Garlow, OW Brawley, VA Master	04/01/2012
Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors. The Canadian journal of urology	DJ Canter, K Ogan, VA Master	04/01/2012
Association between smoking status, and free, total and percent free prostate specific antigen. The Journal of urology	J Li, T Thompson, DA Joseph, VA Master	04/01/2012
Duplicated vena cava with tumor thrombus from renal cancer: use of venogram for safer operative planning. Urology	A Abbasi, TV Johnson, K Ying, D Baumgarten, R Millner, VA Master	04/01/2012
IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms. The Canadian journal of urology	TV Johnson, A Abbasi, SS Ehrlich, RS Kleris, A Owen-Smith, CL Raison, VA Master	02/01/2012
Prostate cancer treatment ascertained from several sources: analysis of disagreement and error. Annals of oncology : official journal of the European Society for Medical Oncology	M Goodman, NK Steenland, ML Almon, JS Liff, CK Dilorio, SO Butler, DU Ekwueme, IJ Hall, JL Smith, VA Master, PL Roberts	01/01/2012
Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International journal of surgical oncology	BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master	01/01/2012
C-reactive protein: a clinically useful biomarker in renal cell carcinoma. JAAPA : official journal of the American Academy of Physician Assistants	TV Johnson, J DeLong, VA Master	01/01/2012
A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the Prostate. Proceedings of SPIE--the International Society for Optical Engineering	B Fei, DM Schuster, V Master, H Akbari, A Fenster, P Nieh	01/01/2012
Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate cancer	J Li, JA Djenaba, A Soman, SH Rim, VA Master	01/01/2012
Posterior lumbar vein off the retrohepatic inferior vena cava: a novel anatomical variant with surgical implications. The Journal of urology	A Abbasi, TV Johnson, R Kleris, K Ying, MY Bonner, SK Maithel, DA Kooby, FF Marshall, VA Master	01/01/2012
Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma. Molecular imaging and biology	B Savir-Baruch, DM Schuster, N Jarkas, VA Master, PT Nieh, RK Halkar, JA Nye, MM Lewis, RJ Crowe, RJ Voll, VM Camp, LM Bellamy, DL Roberts, MM Goodman	12/01/2011
International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. European urology	V Margulis, VA Master, NG Cost, BC Leibovich, S Joniau, M Kuczyk, PF Mulders, Z Kirkali, MP Wirth, Y Hirao, S Rawal, TW Chong, CG Wood	10/01/2011
Review of the relationship between C-reactive protein and exercise. Molecular diagnosis & therapy	A Michigan, TV Johnson, VA Master	10/01/2011
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology	TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master	10/01/2011
Intensive medical student involvement in short-term surgical trips provides safe and effective patient care: a case review. BMC research notes	IL Leeds, FX Creighton, MA Wheatley, JB Macleod, J Srinivasan, MP Chery, VA Master	09/01/2011
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clinical nuclear medicine	R Amzat, P Taleghani, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, MM Lewis, M Faurot, LM Bellamy, MM Goodman, DM Schuster	09/01/2011
Hidden variables: why patients may misunderstand written screening tools. JAAPA : official journal of the American Academy of Physician Assistants	TV Johnson, J DeLong, VA Master	09/01/2011
Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma. Molecular diagnosis & therapy	A Michigan, TV Johnson, VA Master	08/01/2011
Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population. The Canadian journal of urology	W Hsiao, AB Shrewsberry, KA Moses, M Malek-Jones, D Baumgarten, VA Master, K Ogan	08/01/2011
Pediatric adrenal trauma in the 21st century: Children's Hospital of Atlanta experience. The Journal of urology	BD Figler, R Webman, C Ramey, J Kaye, E Patrick, A Kirsch, E Smith, VA Master	07/01/2011
Learning from Haiti. Lancet (London, England)	FX Creighton, IL Leeds, VA Master, JK Srinivasan	06/11/2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology	DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, MM Lewis, JA Nye, W Yu, FD Bowman, MM Goodman	06/01/2011
Initial experience with videoscopic inguinal lymphadenectomy. Annals of surgical oncology	KA Delman, DA Kooby, M Rizzo, K Ogan, V Master	04/01/2011
Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	S Ali, Q Yin-Goen, TV Johnson, W Han, NA Johnson, WB Harris, FF Marshall, AN Young, VA Master, AO Osunkoya	04/01/2011
Medical student surgery elective in rural Haiti: a novel approach to satisfying clerkship requirements while providing surgical care to an underserved population. World journal of surgery	A Chin-Quee, L White, I Leeds, J MacLeod, VA Master	04/01/2011
Minor symptoms are suggestive of metastatic renal cell carcinoma if c-reactive protein remains high after curative nephrectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	A Abbasi, TV Johnson, VA Master	02/20/2011
Observations on prostate intrafraction motion and the effect of reduced treatment time using volumetric modulated arc therapy. Practical radiation oncology	J Shelton, PJ Rossi, H Chen, Y Liu, VA Master, AB Jani	01/01/2011
Automatic 3D Segmentation of Ultrasound Images Using Atlas Registration and Statistical Texture Prior. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, D Schuster, V Master, P Nieh, A Fenster, B Fei	01/01/2011
A PET/CT Directed, 3D Ultrasound-Guided Biopsy System for Prostate Cancer. Prostate cancer imaging : image analysis and image-guided interventions : international workshop held in conjunction with MICCAI 2011, Toronto, Canada, September 22, 2011 : proceedings	B Fei, V Master, P Nieh, H Akbari, X Yang, A Fenster, D Schuster	01/01/2011
C-reactive protein may represent sensitive measure of renal cell carcinoma metastasis. Urologic nursing	TV Johnson, AN Young, S Force, VA Master	01/01/2011
Nocturia associated with depressive symptoms. Urology	TV Johnson, A Abbasi, SS Ehrlich, RS Kleris, CL Raison, VA Master	01/01/2011
Decreased cancer survival in individuals separated at time of diagnosis: Critical period for cancer pathophysiology? Cancer	TV Johnson, VA Master	12/01/2010
Estimated volume growth characteristics of renal tumors undergoing active surveillance. The Canadian journal of urology	CK Hwang, K Ogan, J Pattaras, VA Master	12/01/2010
Major depression drives severity of American Urological Association Symptom Index. Urology	TV Johnson, A Abbasi, SS Ehrlich, RS Kleris, SL Chirumamilla, ED Schoenberg, A Owen-Smith, CL Raison, VA Master	12/01/2010
Multiple potential infectious causes of hematuria complicate this diagnosis. A diagnosis of schistosomiasis is made after four of five possible etiologies are ruled out, illustrating the need to test for all triggers before initiating treatment. JAAPA : official journal of the American Academy of Physician Assistants	TV Johnson, J DeLong, VA Master	10/01/2010
Non-malignant drivers of elevated C-reactive protein levels differ in patients with and without a history of cancer. Molecular diagnosis & therapy	TV Johnson, VA Master	10/01/2010
Radical nephrectomy via epidural-only anesthesia. The Canadian journal of urology	TV Johnson, N Bond, VA Master	10/01/2010
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology	TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master	09/01/2010
Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease. The Journal of urology	W Hsiao, KA Moses, M Goodman, AB Jani, PJ Rossi, VA Master	08/01/2010
The impact of income and education on dietary habits in stone formers. Urology	DT Saint-Elie, PV Patel, KA Healy, T Solomon, JG Pattaras, J Qian, VA Master, K Ogan	08/01/2010
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer	TV Johnson, W Hsiao, KA Delman, AB Jani, OW Brawley, VA Master	06/15/2010
C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma. Molecular diagnosis & therapy	TV Johnson, AN Young, AO Osunkoya, VA Master	06/01/2010
Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis. American journal of clinical oncology	AB Jani, PA Johnstone, SL Liauw, VA Master, PJ Rossi	04/01/2010
Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Annals of surgical oncology	KA Delman, DA Kooby, K Ogan, W Hsiao, V Master	03/01/2010
Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	KA Moses, AT Paciorek, DF Penson, PR Carroll, VA Master	02/20/2010
Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. The Journal of urology	TV Johnson, A Abbasi, A Owen-Smith, A Young, K Ogan, J Pattaras, P Nieh, FF Marshall, VA Master	02/01/2010
Body mass index as a predictor of urological disease and outcomes-overly simplistic? The Journal of urology	VA Master	02/01/2010
Poorly numerate patients in an inner city hospital misunderstand the American Urological Association symptom score. Urology	VA Master, TV Johnson, A Abbasi, SS Ehrlich, RS Kleris, S Abbasi, A Prater, A Owen-Smith, M Goodman	01/01/2010
Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique. European urology	V Master, K Ogan, D Kooby, W Hsiao, K Delman	11/01/2009
Multimedia version of a standard medical questionnaire improves patient understanding across all literacy levels. The Journal of urology	MD Bryant, ED Schoenberg, TV Johnson, M Goodman, A Owen-Smith, VA Master	09/01/2009
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity. American journal of clinical oncology	AB Jani, TH Fox, D Blaustein, PJ Rossi, PA Johnstone, VA Master	06/01/2009
Effects of obesity and weight loss in patients with nononcological urological disease. The Journal of urology	V Natarajan, V Master, K Ogan	06/01/2009
Effect of obesity on urethroplasty outcome. Urology	BN Breyer, JW McAninch, JM Whitson, ML Eisenberg, VA Master, BB Voelzke, SP Elliott	06/01/2009
Combined nephrectomy and major hepatectomy: indications, outcomes, and recommendations. Journal of the American College of Surgeons	M Yezhelyev, V Master, V Egnatashvili, DA Kooby	03/01/2009
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology	PJ Rossi, E Schreibmann, AB Jani, VA Master, PA Johnstone	03/01/2009
Assessment of the performance of the American Urological Association symptom score in 2 distinct patient populations. The Journal of urology	TV Johnson, ED Schoenberg, A Abbasi, SS Ehrlich, R Kleris, A Owen-Smith, K Gunderson, VA Master	01/01/2009
Re: The efficacy of written screening tools in an inner city hospital: literacy based limitations on patient access to appropriate care T. V. Johnson, M. Goodman and V. A. Master J Urol 2007; 178: 623-629. The Journal of urology	D Robinson, TV Johnson, VA Master	10/01/2008
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. American journal of clinical oncology	AB Jani, PA Johnstone, SL Liauw, VA Master, OW Brawley	08/01/2008
Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer	MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, MR Cooperberg, MV Meng, CJ Kane, N Perez, VA Master, PR Carroll	06/15/2008
Minimally invasive endovascular techniques to treat acute renal hemorrhage. The Journal of urology	BN Breyer, JW McAninch, SP Elliott, VA Master	06/01/2008
Patient misunderstanding of the individual questions of the American Urological Association symptom score. The Journal of urology	TV Johnson, A Abbasi, SS Ehrlich, RS Kleris, ED Schoenberg, A Owen-Smith, M Goodman, VA Master	06/01/2008
Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Advances in anatomic pathology	AN Young, VA Master, GP Paner, MD Wang, MB Amin	01/01/2008

Awards

Best Young Investigator Award (2013), American Urological Association (AUA) Research Foundation
Scientific Research Prize (2011), American Urological Association/Olympus Prize Essay Contest
Scientific Research Prize (2010), American Urological Association/Olympus Prize Essay Contest
Best Scientific Poster Presentation (Clinical/Epidemiology/Healthcare) (2009), American Medical Association (7th Annual)
Best Scientific Poster Presentation (Public Health Award) (2009), National Student Research Forum (50th Annual)
Best Scientific Essay Award (Transitional Medicine) (2008), National Student Research Forum (49th Annual)
Best Scientific Poster Presentation (2007), American Urological Association (AUA) Annual Convention

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	12/07/2024	The care provider was exceptional. Kind and caring
One star One star One star One star One star	11/19/2024	I am very pleased with the care that was given to me, and all my questions were answered.
One star One star One star One star One star	11/14/2024	I went in with a set list of questions and Dr Master look over my list going one by one and answered
One star One star One star One star One star	11/12/2024	Dr. Master is an excellent doctor!
One star One star One star One star One star	10/19/2024	Good
One star One star One star One star One star	08/15/2024	Dr. Master has a wonderful bedside manner. He is also a great surgeon to which I can attest.
One star One star One star One star One star	08/06/2024	Good
One star One star One star One star One star	07/11/2024	Dr. Master has been outstanding in addressing my concerns about my healthcare
One star One star One star One star One star	07/11/2024	Dr Master is the best!
One star One star One star One star One star	07/09/2024	Top notch doc
One star One star One star One star One star	07/04/2024	Explained my condition and plan of action as plain as could be and I understood what was going on
One star One star One star One star One star	06/13/2024	Very good
One star One star One star One star One star	06/07/2024	It was a great experience with the nurses,doctor residence doctor's and all medical staff helping with my vosit.
One star One star One star One star One star	06/06/2024	My experience with Dr Master and his team was awesome. Dr Master and his entire team was very thorough. I was impressed by Dr Master and his entire team. This was my 1st experience with Emory Winship Cancer Institute. Everything was explained in detail and felt very comfortable that I would be receiving the best care. The entire team was very professional, and I felt I selected the right team for me.
One star One star One star One star One star	06/04/2024	Dr Master is great!
One star One star One star One star One star	05/02/2024	Everything was top drawer and professional.
One star One star One star One star One star	03/27/2024	No issues with care and follow up
One star One star One star One star One star	03/26/2024	Awesome team of doctors
One star One star One star One star One star	02/15/2024	Good experience
One star One star One star One star One star	01/30/2024	Both Dr. Master and the resident were very attentive and explained my condition in a way that was clear.
One star One star One star One star One star	01/26/2024	Dr. Master is excellent!!!!!!!
One star One star One star One star One star	01/10/2024	I would recommend Dr Master.
One star One star One star One star One star	12/05/2023	Dr Morton was wonderful. He had a very reassuring demeanor. Dr Master was very informative and kind.
One star One star One star One star One star	10/31/2023	Dr. Master appears to be very caring and has a wonderful bed side manner. He never seems rushed when he has seen me.
One star One star One star One star One star	10/19/2023	Dr Master is the BEST. Brilliant, compassionate and kind.
One star One star One star One star One star	10/03/2023	Dr Master is superb. He looks patient on the eye and sends a sense of caring
One star One star One star One star One star	10/03/2023	Good
One star One star One star One star One star	09/05/2023	Dr Master was excellent ... He did a thorough examination and addressed all of my concerns
One star One star One star One star Empty star	08/29/2023	Great
One star One star One star One star One star	08/15/2023	Dr. Masters was very thorough, and put me at ease answered all my questions. Emory is very lucky to have such an esteemed doctor as Dr. Masters
One star One star One star One star One star	08/09/2023	Love concern and care was shown by everyone
One star One star One star One star One star	08/08/2023	Dr. Master is great. He takes time to explain everything. Also, answers all my questions. He has a great attitude and extremely friendly!! I have recommended him to several people in the past and will continue to recommend Emory and him to others.
One star One star One star One star One star	08/08/2023	Dr Master is exceptional in every respect! I consider myself tremendously fortunate to have been his patient!!
One star One star One star One star One star	07/27/2023	Good experience
One star One star One star One star One star	07/25/2023	Dr. Master was informative, direct,and compassionate. Very intelligent man.
One star One star One star One star One star	07/13/2023	Exceptional Physician
One star One star One half star Empty star Empty star	07/11/2023	Doctor was most helpful.
One star One star One star One star One star	06/20/2023	We were referred to Dr. Master from NGHS and within five minutes he was able to develop a treatment plan for my kidney cancer.
One star One star One star One star Empty star	06/15/2023	Good
One star One star One star One star One star	06/13/2023	Dr. Master is an excellent and caring doctor. He truly cares about improving the quality of life for his patients. Many thanks to him and his staff.
One star One star One star One star One star	06/08/2023	Dr Master was very professional and explained everything to me
One star One star One star One star One star	06/06/2023	Caregivers were very nice and professional!
One star One star One star One star One star	05/23/2023	Dr. Master is a wonderful provider with a tremendous amount of knowledge and skill. My prognosis has been positive mostly due to Dr. Master's talent.
One star One star One star One star One star	03/14/2023	Information provided by Dr. Masters we felt was concise and gave us the opportunity to make a good combined decision.
One star One star One star One star One star	03/02/2023	From start to finish of my care at Emory has been nothing but exemplary.
One star One star One star One star One star	01/30/2023	Everyone was professional and attentive.
One star One star One star One star One star	01/27/2023	Good experience